Phosphorylation based Models of Neurodegenerative Diseases

Aberrant protein phosphorylation is a hallmark of neurodegenerative diseases, such as Alzheimer's disease (AD) and tauopathies. Pathological phosphorylation is commonly observed as intracellular tau containing deposits correlating with neuronal death. Tau is a cytoskeletal protein, key to the s...

Full description

Bibliographic Details
Main Author: Koss, David John
Published: University of Aberdeen 2008
Subjects:
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.485668
id ndltd-bl.uk-oai-ethos.bl.uk-485668
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-4856682017-12-24T16:49:03ZPhosphorylation based Models of Neurodegenerative DiseasesKoss, David John2008Aberrant protein phosphorylation is a hallmark of neurodegenerative diseases, such as Alzheimer's disease (AD) and tauopathies. Pathological phosphorylation is commonly observed as intracellular tau containing deposits correlating with neuronal death. Tau is a cytoskeletal protein, key to the stabilisation of the microtubules (MT), important ,for structural integrity and protein trafficking. Tau's ability to promote MTs is regulated by protein phosphorylation by kinases/phosphatases. In spontaneous AD, the activity/expression of kinases are enhanced w$ilst phosphatases are decreased. Alterations in phosphorylation have significant regulatory effects on neuronal signalling which may lead to deficits in neuronal signalling prior to neuronal death. Using cultured rat hippocampal neurons and pharmacological inhibitors of serine/threonine (Okadaic acid and Cantharidin) and tyrosine (Sodium orthovanadate) phosphatases, the consequences of increased phosphorylation for neuronal signalling were investigated. Using Fura-2 Ca2+ imaging, serine/threonine phosphatase inhibition was determined to exert bidirectional modulation on neuronal excitability. Low level short duration inhibition enhanced, whilst str9nger or more prolonged inhibition suppressed Ca2 + responses towards stimulation. Suppression of excitability was coincident with' a reduction in receptor expression and an increase in cytoskeletal phosphorylation. The data mimic changes in signalling utilising alternative means of modelling AD, suggesting that common ' phosphorylation cascades may be active within these models and in the disease process. Acute inhibition of tyrosine phosphatases evoked a prolonged Ca2 + response dependent on the activation of trans-plasma membrane Ca2+ channels. Prolonged inhibition of tyrosine phosphatases enhanced neuronal excitability. A novel sponge toxin polymeric 1,3-alkylpyridinium salts was employed as an agent for inducing tau over-expression in cultured neurons and further Ca2 + imaging studies conducted. Modulation on excitability was observed to be dependent on the level oftau expression. Overall, this thesis furthers the understanding of phospho-regulation of neuronal signalling ~oth physiologically, and pathologically and provides preliminary data for novel roles of tau in neuronal signalling regulation.616.8University of Aberdeenhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.485668Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 616.8
spellingShingle 616.8
Koss, David John
Phosphorylation based Models of Neurodegenerative Diseases
description Aberrant protein phosphorylation is a hallmark of neurodegenerative diseases, such as Alzheimer's disease (AD) and tauopathies. Pathological phosphorylation is commonly observed as intracellular tau containing deposits correlating with neuronal death. Tau is a cytoskeletal protein, key to the stabilisation of the microtubules (MT), important ,for structural integrity and protein trafficking. Tau's ability to promote MTs is regulated by protein phosphorylation by kinases/phosphatases. In spontaneous AD, the activity/expression of kinases are enhanced w$ilst phosphatases are decreased. Alterations in phosphorylation have significant regulatory effects on neuronal signalling which may lead to deficits in neuronal signalling prior to neuronal death. Using cultured rat hippocampal neurons and pharmacological inhibitors of serine/threonine (Okadaic acid and Cantharidin) and tyrosine (Sodium orthovanadate) phosphatases, the consequences of increased phosphorylation for neuronal signalling were investigated. Using Fura-2 Ca2+ imaging, serine/threonine phosphatase inhibition was determined to exert bidirectional modulation on neuronal excitability. Low level short duration inhibition enhanced, whilst str9nger or more prolonged inhibition suppressed Ca2 + responses towards stimulation. Suppression of excitability was coincident with' a reduction in receptor expression and an increase in cytoskeletal phosphorylation. The data mimic changes in signalling utilising alternative means of modelling AD, suggesting that common ' phosphorylation cascades may be active within these models and in the disease process. Acute inhibition of tyrosine phosphatases evoked a prolonged Ca2 + response dependent on the activation of trans-plasma membrane Ca2+ channels. Prolonged inhibition of tyrosine phosphatases enhanced neuronal excitability. A novel sponge toxin polymeric 1,3-alkylpyridinium salts was employed as an agent for inducing tau over-expression in cultured neurons and further Ca2 + imaging studies conducted. Modulation on excitability was observed to be dependent on the level oftau expression. Overall, this thesis furthers the understanding of phospho-regulation of neuronal signalling ~oth physiologically, and pathologically and provides preliminary data for novel roles of tau in neuronal signalling regulation.
author Koss, David John
author_facet Koss, David John
author_sort Koss, David John
title Phosphorylation based Models of Neurodegenerative Diseases
title_short Phosphorylation based Models of Neurodegenerative Diseases
title_full Phosphorylation based Models of Neurodegenerative Diseases
title_fullStr Phosphorylation based Models of Neurodegenerative Diseases
title_full_unstemmed Phosphorylation based Models of Neurodegenerative Diseases
title_sort phosphorylation based models of neurodegenerative diseases
publisher University of Aberdeen
publishDate 2008
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.485668
work_keys_str_mv AT kossdavidjohn phosphorylationbasedmodelsofneurodegenerativediseases
_version_ 1718579709637296128